Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 13 Aug 24 424B3 Prospectus supplement
- 30 Jul 24 424B3 Prospectus supplement
- 15 May 24 424B3 Prospectus supplement
- 3 Apr 24 EFFECT Notice of effectiveness
- 29 Mar 24 POS AM Prospectus update (post-effective amendment)
- 29 Jan 24 EFFECT Notice of effectiveness
- 25 Jan 24 S-1/A IPO registration (amended)
- 25 Jan 24 S-1/A IPO registration (amended)
- 22 Jan 24 S-1/A IPO registration (amended)
- 10 Jan 24 UPLOAD Letter from SEC
-
3 Jan 24 S-1 IPO registration
PBLA similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation in this Registration Statement on Form S-1 of our report dated March 16, 2023 relating to the consolidated financial statements of Panbela Therapeutics, Inc. and its subsidiaries as of and for the years ended December 31, 2022 and 2021, and to the reference of our firm under the caption “Experts” in the Registration Statement.
/s/ Cherry Bekaert LLP
Tampa, Florida
January 3, 2024